The Systemic Immune-inflammation Index (SII) Is an Independent Prognostic Factor for Patients With Recurrent Esophageal Cancer After Esophagectomy
The SII was an independent prognostic factor. In addition, the SII affects the clinical course of treatment after recurrence. Therefore, physicians might have a chance to make better decisions for treatment and management of recurrent EC using the SII.
Authors
- MOMOKO FUKUDA (ORCID: https://orcid.org/0000-0002-3653-5790)
- Naoko Okuda
- Toru Aoyama
- HARUHIKO CHO
- ITARU HASHIMOTO (ORCID: https://orcid.org/0000-0002-8398-1494)
- NATSUMI KAMIYA
- MIWHA JU
- Keisuke Kazama (ORCID: https://orcid.org/0000-0002-8155-8561)
- Norio Yukawa (ORCID: https://orcid.org/0000-0003-0411-6353)
- Aya Saito (ORCID: https://orcid.org/0000-0001-6731-2007)
- Hideaki Suematsu
- Ryuki Esashi
- Sosuke Yamamoto
- Yukio Maezawa
- AYAKO TAMAGAWA
- Kinji Shimada
Institutions
- Tokyo Metropolitan Komagome Hospital (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.14031
- Citations
- 2
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.09